Cardiovascular disease management during the coronavirus disease 2019 pandemic

Based on clinical presentation, pathophysiology, high infectivity, high cardiovascular involvement, and therapeutic agents with cardiovascular toxicity of coronavirus disease 2019 (COVID-19), regular cardiovascular treatment is being changing greatly. Despite angiotensin-converting enzyme 2 serving...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int J Med Sci
Главные авторы: Lee, Wen-Hsien, Chen, Ying-Chih, Chen, Szu-Chia, Chen, Chang-Jen, Hsu, Po-Chao, Tsai, Wei-Chung, Chu, Chun-Yuan, Lee, Chee-Siong, Lin, Tsung-Hsien, Voon, Wen-Chol, Kuo, Chao-Hung, Su, Ho-Ming
Формат: Artigo
Язык:Inglês
Опубликовано: Ivyspring International Publisher 2020
Предметы:
Review
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7330658/
https://ncbi.nlm.nih.gov/pubmed/32624690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.46484
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы